Revelation Pharma Completes Sixteenth Acquisition – Rock Valley Compounding Pharmacy

Revelation Pharma Completes Sixteenth Acquisition – Adding Rock Valley Compounding Pharmacy to the Revelation Pharma Network

TAMPA, Fla., – Osceola Capital (“Osceola”), a lower middle-market private equity firm, announced today the sixteenth addition to the Revelation Pharma Corporation (“Revelation”) platform. Revelation purchased Rock Valley Compounding Pharmacy located in Rockford, Illinois. Rock Valley takes immense pride in offering high-quality, specialized treatments while collaborating closely with prescribing physicians to guarantee the best possible health outcomes for each patient.

The acquisition of Rock Valley Compounding Pharmacy represents Revelation’s ongoing goal to establish a nationwide network of 503A and 503B compounding pharmacies. Compounding pharmacies create high-quality, personalized prescriptions to address a particular therapeutic need, frequently improving the quality of life for patients.

“I’m very happy that Rock Valley Compounding will join Revelation’s vast network of compounding pharmacies! Rock Valley gives priority to meeting the health care needs of patients.  Now with collaborating with some of the greatest and brightest, joining Revelation gives us a chance to further support both health care providers and their patients by dispensing unique compounded therapies,” said Jonathan Lehan, PharmD, owner of Rock Valley Compounding Pharmacy.

The corporate team for Revelation is led by pharmacist and CEO Shawn Hodges, the former CEO and President of Innovation Compounding. Jake Beckel and Richard Case, the founders of Revelation, who also reside on the board of directors, will solely focus on helping new companies seeking to join Revelation. Mitchell Bell PharmD., is the Senior Vice President of 503A Pharmacies, Will Skinner is the Chief Financial Officer who has specialized in start-ups, and investment companies. Jon Pritchett PharmD., former Pharmacy Program Director at Accreditation Commission for Health Care (ACHC), now serves as the Vice President of Quality Assurance and Regulatory Affairs.

Despite changes in regulatory requirements and practice standards, as well as an increased cost of doing business, the market need for pharmacy compounding continues to grow.  Revelation is a buy-and-build company, offering owners a rewarding exit strategy but allow their pharmacy to remain part of the local healthcare community.  

About Osceola Capital Management

Osceola Capital is a Tampa-based private equity firm that invests in lower middle-market services companies, typically with EBITDA of $2 million to $10 million. Osceola has extensive experience partnering with management teams to execute buy-and-build strategies and drive long-term value creation. The Revelation Strategy Team includes Ben Moe, and Patrick Watkins. To learn more, visit

About Revelation Pharma Corporation

Revelation Pharma is a national network of 503A and 503B compounding pharmacies providing innovative and quality pharmaceutical products and services through “industry best” patient care and solutions for customers. Compounding pharmacy will drastically change in the next five years. Revelation believes that compounding pharmacies will need help and support to adjust to these changes to continue to serve the needs of the patient and their healthcare provider.

About Rock Valley Compounding Pharmacy

Rock Valley Compounding Pharmacy is a 503A compounding pharmacy that specializes in BHRT, pain management, veterinary compounding, anti-aging, resolving drug shortages, and much more.



Olivia Scott

Director of Marketing Communications

Proud Pharmacy Member - Alliance for Pharmacy Compounding

Change the future of compounding pharmacy with us

If you have any specific questions about what an exit/partnership opportunity looks like with Revelation, please contact